233 related articles for article (PubMed ID: 21310403)
21. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
Ballesteros V; Costa O; Iñiguez C; Fletcher T; Ballester F; Lopez-Espinosa MJ
Environ Int; 2017 Feb; 99():15-28. PubMed ID: 27884404
[TBL] [Abstract][Full Text] [Related]
22. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
[TBL] [Abstract][Full Text] [Related]
23. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
[TBL] [Abstract][Full Text] [Related]
24. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
25. Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008).
Webster GM; Rauch SA; Marie NS; Mattman A; Lanphear BP; Venners SA
Environ Health Perspect; 2016 Jul; 124(7):935-42. PubMed ID: 26517287
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
Chang SC; Thibodeaux JR; Eastvold ML; Ehresman DJ; Bjork JA; Froehlich JW; Lau C; Singh RJ; Wallace KB; Butenhoff JL
Toxicology; 2008 Jan; 243(3):330-9. PubMed ID: 18063289
[TBL] [Abstract][Full Text] [Related]
27. PFOA and PFOS are associated with reduced expression of the parathyroid hormone 2 receptor (PTH2R) gene in women.
Galloway TS; Fletcher T; Thomas OJ; Lee BP; Pilling LC; Harries LW
Chemosphere; 2015 Feb; 120():555-62. PubMed ID: 25462297
[TBL] [Abstract][Full Text] [Related]
28. Retrospective monitoring of perfluorocarboxylates and perfluorosulfonates in human plasma archived by the German Environmental Specimen Bank.
Schröter-Kermani C; Müller J; Jürling H; Conrad A; Schulte C
Int J Hyg Environ Health; 2013 Nov; 216(6):633-40. PubMed ID: 22999890
[TBL] [Abstract][Full Text] [Related]
29. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones.
Ji K; Kim S; Kho Y; Paek D; Sakong J; Ha J; Kim S; Choi K
Environ Int; 2012 Sep; 45():78-85. PubMed ID: 22580293
[TBL] [Abstract][Full Text] [Related]
30. Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
Cirello V; Lugaresi M; Moneta C; Dufour P; Manzo A; Carbone E; Colombo C; Fugazzola L; Charlier C; Pirard C
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657654
[TBL] [Abstract][Full Text] [Related]
31. The effect of ongoing blood loss on human serum concentrations of perfluorinated acids.
Lorber M; Eaglesham GE; Hobson P; Toms LM; Mueller JF; Thompson JS
Chemosphere; 2015 Jan; 118():170-7. PubMed ID: 25180653
[TBL] [Abstract][Full Text] [Related]
32. Concentrations of perfluorinated compounds in human blood from twelve cities in China.
Pan Y; Shi Y; Wang J; Cai Y; Wu Y
Environ Toxicol Chem; 2010 Dec; 29(12):2695-701. PubMed ID: 20973108
[TBL] [Abstract][Full Text] [Related]
33. ADONA and perfluoroalkylated substances in plasma samples of German blood donors living in South Germany.
Fromme H; Wöckner M; Roscher E; Völkel W
Int J Hyg Environ Health; 2017 Apr; 220(2 Pt B):455-460. PubMed ID: 28073630
[TBL] [Abstract][Full Text] [Related]
34. No association between exposure to perfluorinated compounds and congenital cryptorchidism: a nested case-control study among 215 boys from Denmark and Finland.
Vesterholm Jensen D; Christensen J; Virtanen HE; Skakkebæk NE; Main KM; Toppari J; Veje CW; Andersson AM; Nielsen F; Grandjean P; Jensen TK
Reproduction; 2014; 147(4):411-7. PubMed ID: 24218628
[TBL] [Abstract][Full Text] [Related]
35. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults.
Lin CY; Wen LL; Lin LY; Wen TW; Lien GW; Hsu SH; Chien KL; Liao CC; Sung FC; Chen PC; Su TC
J Hazard Mater; 2013 Jan; 244-245():637-44. PubMed ID: 23177245
[TBL] [Abstract][Full Text] [Related]
36. Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate.
Lopez-Espinosa MJ; Fitz-Simon N; Bloom MS; Calafat AM; Fletcher T
Reprod Toxicol; 2012 Jul; 33(4):552-555. PubMed ID: 21530636
[TBL] [Abstract][Full Text] [Related]
37. Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.
Hsu JY; Hsu JF; Ho HH; Chiang CF; Liao PC
Chemosphere; 2013 Sep; 93(3):532-7. PubMed ID: 23886440
[TBL] [Abstract][Full Text] [Related]
38. Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study.
Martinsson M; Nielsen C; Björk J; Rylander L; Malmqvist E; Lindh C; Rignell-Hydbom A
PLoS One; 2020; 15(3):e0230137. PubMed ID: 32176721
[TBL] [Abstract][Full Text] [Related]
39. Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review.
Boesen SAH; Long M; Wielsøe M; Mustieles V; Fernandez MF; Bonefeld-Jørgensen EC
Environ Health; 2020 Oct; 19(1):107. PubMed ID: 33050930
[TBL] [Abstract][Full Text] [Related]
40. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
